Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry-Reference-Cited by-同舟云学术

Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry

Author:

Klein A¹²,Becker I³,Minden K⁴,Foeldvari I⁵,Haas JP⁶,Horneff G¹²

Affiliation:

1. Department of Paediatrics, Centre for Paediatric Rheumatology, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany

2. Medical Faculty, University of Cologne, Cologne, Germany

3. Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany

4. German Rheumatism Research Centre Berlin, and Charité University Medicine, Berlin, Germany

5. Hamburg Centre of Paediatric and Adolescent Rheumatology, Hamburg, Germany

6. German Centre for Paediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany

Funder

AbbVie Deutschland

Chugai Pharmaceutical

F. Hoffmann-La Roche

Merck Sharp and Dohme

Pfizer

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

Reference26 articles.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献